| scholarly article | Q13442814 |
| P2093 | author name string | X S Wang | |
| A Srivastava | |||
| P Mukherjee | |||
| D M Kube | |||
| K Qing | |||
| S Ponnazhagan | |||
| C Mah | |||
| M C Yoder | |||
| E F Srour | |||
| C Kurpad | |||
| P2860 | cites work | Thalassemia--a global public health problem | Q40933017 |
| Gene transfer to hematopoietic cells | Q41004925 | ||
| Differential expression in human cells from the p6 promoter of human parvovirus B19 following plasmid transfection and recombinant adeno-associated virus 2 (AAV) infection: human megakaryocytic leukaemia cells are non-permissive for AAV infection | Q41195377 | ||
| Adeno-associated virus type 2 binds to a 150-kilodalton cell membrane glycoprotein | Q41226028 | ||
| Murine embryonic yolk sac cells promote in vitro proliferation of bone marrow high proliferative potential colony-forming cells | Q41311969 | ||
| Rescue of the Adeno-Associated Virus 2 Genome Correlates with Alterations in DNA-Modifying Enzymes in Human Cells | Q43986376 | ||
| Integration of adeno-associated virus vectors in CD34+ human hematopoietic progenitor cells after transduction. | Q44920945 | ||
| Myeloproliferative sarcoma virus directed expression of beta-galactosidase following retroviral transduction of murine hematopoietic cells | Q45788174 | ||
| Gene therapy | Q72002887 | ||
| Parvovirus replication | Q24634739 | ||
| Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors | Q24682739 | ||
| Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis | Q24684374 | ||
| Selective extraction of polyoma DNA from infected mouse cell cultures | Q29547500 | ||
| Combination of interleukins 3 and 6 preserves stem cell function in culture and enhances retrovirus-mediated gene transfer into hematopoietic stem cells | Q34319610 | ||
| Adeno-associated virus 2-mediated gene transfer in vivo: organ-tropism and expression of transduced sequences in mice | Q34429058 | ||
| Use of Adeno-Associated Virus as a General Transduction Vector for Mammalian Cells | Q35228018 | ||
| Adeno-associated virus type 2-mediated transduction of murine hematopoietic cells with long-term repopulating ability and sustained expression of a human globin gene in vivo | Q35881204 | ||
| Adeno-associated virus 2-mediated high efficiency gene transfer into immature and mature subsets of hematopoietic progenitor cells in human umbilical cord blood | Q36363237 | ||
| Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection | Q36720691 | ||
| Isolation of a candidate human hematopoietic stem-cell population | Q36922569 | ||
| Adeno-associated viruses: an update. | Q39511024 | ||
| Recombinant adeno-associated virus mediates a high level of gene transfer but less efficient integration in the K562 human hematopoietic cell line | Q39878393 | ||
| Gene therapy for human hemoglobinopathies | Q40777249 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 8262-8267 | |
| P577 | publication date | 1997-11-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Adeno-associated virus type 2-mediated transduction in primary human bone marrow-derived CD34+ hematopoietic progenitor cells: donor variation and correlation of transgene expression with cellular differentiation | |
| P478 | volume | 71 |
| Q41936136 | A directed evolution approach to select for novel Adeno-associated virus capsids on an HIV-1 producer T cell line. |
| Q90707116 | AAV D-sequence-mediated suppression of expression of a human major histocompatibility class II gene: Implications in the development of AAV vectors for modulating humoral immune response |
| Q38685537 | Adeno-Associated Virus Vectors and Stem Cells: Friends or Foes? |
| Q34998573 | Adeno-associated virus capsids displaying immunoglobulin-binding domains permit antibody-mediated vector retargeting to specific cell surface receptors |
| Q33839187 | Adeno-associated virus type 2-mediated gene transfer: altered endocytic processing enhances transduction efficiency in murine fibroblasts |
| Q34070164 | Adeno-associated virus type 2-mediated gene transfer: correlation of tyrosine phosphorylation of the cellular single-stranded D sequence-binding protein with transgene expression in human cells in vitro and murine tissues in vivo |
| Q24529167 | Adeno-associated virus type 2-mediated gene transfer: role of cellular FKBP52 protein in transgene expression |
| Q34472029 | Adeno-associated virus type 2-mediated gene transfer: role of cellular T-cell protein tyrosine phosphatase in transgene expression in established cell lines in vitro and transgenic mice in vivo |
| Q33786039 | Adeno-associated virus type 2-mediated gene transfer: role of epidermal growth factor receptor protein tyrosine kinase in transgene expression |
| Q33846007 | Adeno-associated virus type 2-mediated transduction of human monocyte-derived dendritic cells: implications for ex vivo immunotherapy |
| Q33695816 | Adeno-associated virus vectors and hematology |
| Q34317131 | Adeno-associated virus-mediated gene transfer |
| Q45861914 | Adenovirus-mediated expresssion of the murine ecotropic receptor facilitates transduction of human hematopoietic cells with an ecotropic retroviral vector. |
| Q33905819 | Adoptively transferred ex vivo expanded gammadelta-T cells mediate in vivo antitumor activity in preclinical mouse models of breast cancer. |
| Q33369214 | Application of a haematopoetic progenitor cell-targeted adeno-associated viral (AAV) vector established by selection of an AAV random peptide library on a leukaemia cell line |
| Q44239568 | Baculovirus transduction of human mesenchymal stem cell-derived progenitor cells: variation of transgene expression with cellular differentiation states |
| Q34354192 | Conjugate-based targeting of recombinant adeno-associated virus type 2 vectors by using avidin-linked ligands |
| Q36143446 | Current status of gene therapy strategies to treat HIV/AIDS. |
| Q45151455 | Efficient gene transfer into human cord blood CD34+ cells and the CD34+CD38- subset using highly purified recombinant adeno-associated viral vector preparations that are free of helper virus and wild-type AAV. |
| Q45748024 | Efficient gene transfer into human keratinocytes with recombinant adeno-associated virus vectors |
| Q45868429 | Efficient gene transfer to hematopoietic progenitor cells using SV40-derived vectors |
| Q91809423 | Enhanced Transduction of Human Hematopoietic Stem Cells by AAV6 Vectors: Implications in Gene Therapy and Genome Editing |
| Q44147819 | Ex vivo transduced liver progenitor cells as a platform for gene therapy in mice |
| Q33702182 | Gene therapy for chronic myelogenous leukemia |
| Q35618574 | Gene transfer properties and structural modeling of human stem cell-derived AAV. |
| Q36004744 | Heat-shock treatment-mediated increase in transduction by recombinant adeno-associated virus 2 vectors is independent of the cellular heat-shock protein 90 |
| Q37349186 | High-Efficiency Transduction of Primary Human Hematopoietic Stem/Progenitor Cells by AAV6 Vectors: Strategies for Overcoming Donor-Variation and Implications in Genome Editing. |
| Q34629995 | High-efficiency transduction of primary human hematopoietic stem cells and erythroid lineage-restricted expression by optimized AAV6 serotype vectors in vitro and in a murine xenograft model in vivo |
| Q34486856 | Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2. |
| Q35131229 | Immune responses to adeno-associated virus and its recombinant vectors |
| Q33796712 | Impaired intracellular trafficking of adeno-associated virus type 2 vectors limits efficient transduction of murine fibroblasts |
| Q34772131 | In vivo induction of human immunodeficiency virus type 1 entry into nucleus-free cells by CD4 gene transfer to hematopoietic stem cells: a hypothetical possible strategy for therapeutic intervention |
| Q50777152 | Lentiviral vectors pseudotyped with glycoproteins from Ross River and vesicular stomatitis viruses: variable transduction related to cell type and culture conditions. |
| Q24515072 | Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism |
| Q37011792 | Optimizing the transduction efficiency of capsid-modified AAV6 serotype vectors in primary human hematopoietic stem cells in vitro and in a xenograft mouse model in vivo. |
| Q35155102 | Parvovirus infection suppresses long-term repopulating hematopoietic stem cells |
| Q34150872 | Primary human cells differ in their susceptibility to rAAV-2-mediated gene transfer and duration of reporter gene expression |
| Q42580337 | Pseudotyped adeno-associated viral vectors for gene transfer in dermal fibroblasts: implications for wound-healing applications. |
| Q34194223 | RGD inclusion in VP3 provides adeno-associated virus type 2 (AAV2)-based vectors with a heparan sulfate-independent cell entry mechanism |
| Q45734168 | Rapid induction of cytotoxic T-cell response against cervical cancer cells by human papillomavirus type 16 E6 antigen gene delivery into human dendritic cells by an adeno-associated virus vector |
| Q40933734 | Recombinant AAV-2 harboring gfp-antisense/ribozyme fusion sequences monitor transduction, gene expression, and show anti-HIV-1 efficacy |
| Q34737801 | Recombinant human parvovirus B19 vectors |
| Q33784686 | Recombinant human parvovirus B19 vectors: erythroid cell-specific delivery and expression of transduced genes |
| Q35972733 | Self-Complementary Adeno-Associated Virus Vectors Improve Transduction Efficiency of Corneal Endothelial Cells |
| Q34804660 | Self-complementary AAV vectors; advances and applications |
| Q59356657 | Stem cell-derived clade F AAVs mediate high-efficiency homologous recombination-based genome editing |
| Q39551710 | Structure of adeno-associated virus vector DNA following transduction of the skeletal muscle |
| Q40921572 | Superior gene transfer into solid tumour cells than into human mobilised peripheral blood progenitor cells using helpervirus-free adeno-associated viral vector stocks |
Search more.